Document Detail

Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
MedLine Citation:
PMID:  23225457     Owner:  NLM     Status:  In-Data-Review    
PATIENTS AND METHODS: A total of 87 children were tested at diagnosis for ITRT and for persistence of blasts in bone marrow at day 15 (BML15>0.5%) and were followed-up in long-term analysis.
RESULTS: The probability of disease-free survival (pDFS) was significantly better for patients with an ITRT profile showing sensitivity to prednisolone, vincristine, daunorubicin, and L-asparaginase. Patients with BML15>0.5% had higher ITRT for prednisolone, daunorubicin, L-asparaginase, and etoposide. Three factors had predictive impact for relapse: BML15>0.5%, ITRT for prednisolone and high combined ITRT profile for prednisolone, vincristine and L-asparaginase (PVA score).
CONCLUSION: Persistence of blasts in bone marrow at day 15, ITRT showing resistance to prednisolone and high PVA score were the strongest and comparable prognostic factors predicting relapse in childhood ALL.
Jan Styczynski; Magdalena Piatkowska; Anna Jaworska-Posadzy; Krzysztof Czyzewski; Malgorzata Kubicka; Beata Kolodziej; Beata Kurylo-Rafinska; Robert Debski; Monika Pogorzala; Mariusz Wysocki
Related Documents :
8528057 - Clinical experience with fludarabine and its immunosuppressive effects in pretreated ch...
15359647 - Detection of trisomy 8 in donor-derived ph- cells in a patient with ph+ chronic myeloid...
24962937 - International multi-institutional management and outcome of melanoma patients with posi...
19863337 - P53 expression by immunohistochemistry is an important determinant of survival in patie...
24553727 - Clinical, radiological, and pathological features of 16 papillary glioneuronal tumors.
23417697 - Maintenance single-agent bevacizumab or observation after first-line chemotherapy in pa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  5495-9     Citation Subset:  IM    
Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, ul. Curie-Sklodowskiej 9, 85-094 Bydgoszcz, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hepatic arterial infusion of irinotecan, 5-Fluorouracil and leucovorin in patients with liver metast...
Next Document:  Bevacizumab plus docetaxel and cisplatin for metastatic breast cancer: a pilot phase II study.